Icotec receives authorizations for implant systems
Altstätten SG – The MedTech company icotec ag has received authorizations in the USA and Europe for two spinal implant systems. This will allow commercialization activities to be launched in both regions in the near future.
The US Food and Drug Administration (FDA) has granted FDA-510(k) clearance to the KONG-TL and KONG-C vertebral body replacement systems developed by icotec ag. The company has also been awarded European CE approval for its implant system featuring a “unique titanium coating”, as detailed in a press release issued by the MedTech firm based in the St.GallenBodenseeArea.
Vertebral body replacement systems are used to reconstruct and stabilize the spine. As the “global market leader in surgical treatment of vertebral tumors”, icotec ag has set itself the goal of using its product portfolio to offer improved treatment options for patients. Roger Stadler, CEO of icotec, explained in the press release that company has taken a few large steps in the direction of achieving this aim with the imminent market launch of the KONG-TL/C vertebral body replacement systems in Europe and the USA.